Metraipolis › archive › dc_38eda94da251

Screening of cell-type-specific meta-programs for drug repurposing in Alzheimer's disease — Europe PMC PMID:42506875

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42506875
DOI
10.1093/bib/bbag411
License (as archived)
solo-consultazione
Archived
2026-10-07T22:26:08.550Z
SHA-256 of the archived text
332f7976b351c6661befc57f403187e21023fbf50a41b81e28e3939b0a5fd6b0
Stable URL of this page
https://metraipolis.com/documento/dc_38eda94da251

How to cite

Screening of cell-type-specific meta-programs for drug repurposing in Alzheimer's disease — Europe PMC PMID:42506875 — Europe PMC (en), https://europepmc.org/article/MED/42506875 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_38eda94da251 (Metraipolis archive dc_38eda94da251, sha256 332f7976b351c6661befc57f403187e21023fbf50a41b81e28e3939b0a5fd6b0)
BibTeX
@misc{dc38eda94da251,
  title = {Screening of cell-type-specific meta-programs for drug repurposing in Alzheimer's disease — Europe PMC PMID:42506875},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42506875},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_38eda94da251; sha256 332f7976b351c6661befc57f403187e21023fbf50a41b81e28e3939b0a5fd6b0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42506875. Agents can read the archived copy with the MCP tool read_document.